Skip to main content
Caplight Logo









Hawkhill Therapeutics

Hawkhill Therapeutics

Private
DundeeHealthcare & Life Scienceshttps://hawkhilltherapeutics.com/

Last Round

Seed Round

Jun 23, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hawkhill Therapeutics is a biotechnology company developing a first-in-class oral therapy for obesity that selectively reduces fat while preserving muscle mass.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

obesity treatmentsmall molecule therapeuticsmetabolic healthGLP-1 alternativemuscle-sparing therapydrug discoveryvirtual biotechweight loss drugbiotechnologycontract research organizationCROpharmaceutical licensingobesity drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hawkhill Therapeutics Comparables

Compare Hawkhill Therapeutics with similar companies based on industry and business-model similarity.

Hawkhill Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iBio, Inc.
74%
Eccogene
73%
Veru Inc.
72%

Hawkhill Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 23, 2026
Early FundingJul 4, 2025

Key People

Founding team and executive leadership

Andrew Woodland

Chief Executive Officer

Executive Team

Mark Bell

CTO

Executive Team

Conor Woolfson

Chief Financial Officer

Executive Team

Hawkhill Therapeutics Investors

Notable investors and investment history

Hawkhill Therapeutics investors
InvestorRounds
o2h venturesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $193K raised in Seed Round.

  • Nov 11, 2025

    Grew 60% QoQ, from 5 to 8 employees.

Hawkhill Therapeutics Filings

Explore SEC and related filing metadata, where available.

Hawkhill Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hawkhill Therapeutics's valuation, stock price, and market status.

Is Hawkhill Therapeutics a public or private company?

Hawkhill Therapeutics is a private company.

What is the current stock price of Hawkhill Therapeutics?

Hawkhill Therapeutics is a private company with no public stock price. Caplight tracks Hawkhill Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Hawkhill Therapeutics worth (valuation)?

Valuation information for Hawkhill Therapeutics is not publicly available.

Can I buy Hawkhill Therapeutics stock?

Hawkhill Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hawkhill Therapeutics's last funding round?

Hawkhill Therapeutics's most recent funding round was Seed Round on June 23, 2026.

Who are the main investors in Hawkhill Therapeutics?

Key investors in Hawkhill Therapeutics include o2h ventures.

Will Hawkhill Therapeutics IPO soon?

No public IPO plans have been announced for Hawkhill Therapeutics.

How can I track Hawkhill Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hawkhill Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDundee
Employee Range8
Year Founded2025
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?